| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8786671 | European Journal of Surgical Oncology (EJSO) | 2018 | 26 Pages |
Abstract
Since the implementation of ERAS protocols, LOS has decreased for nine out of ten MSOPs in a significant fashion. Although these gains may appear marginal on an annual basis, their cumulative effect, over the study span, ranges for 7.7%-49.2%, which can hardly be interpreted as marginal. LOS decrease directly translates in THCGs savings.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Sebastiano Nazzani, Felix Preisser, Elio Mazzone, Zhe Tian, Francesco A. Mistretta, Shahrokh F. Shariat, Fred Saad, Markus Graefen, Derya Tilki, Emanuele Montanari, Stefano Luzzago, Alberto Briganti, Luca Carmignani, Pierre I. Karakiewicz,